U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H38N2O.ClH
Molecular Weight 419.043
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUNAMIDINE HYDROCHLORIDE

SMILES

Cl.CCCCCCOC1=CC=C(C(=N)N(CCCC)CCCC)C2=CC=CC=C12

InChI

InChIKey=PBYJDHRFPFHVKZ-UHFFFAOYSA-N
InChI=1S/C25H38N2O.ClH/c1-4-7-10-13-20-28-24-17-16-23(21-14-11-12-15-22(21)24)25(26)27(18-8-5-2)19-9-6-3;/h11-12,14-17,26H,4-10,13,18-20H2,1-3H3;1H

HIDE SMILES / InChI

Description

Bunamidine is a anti-parasitic drug, which was approved by FDA for the treatment of tapeworms in cats and dogs (Scolaban 400 tablets).

Approval Year

Unknown
139,594

Conditions

ConditionModalityTargetsHighest PhaseProduct
Tapeworm infection
8
 Curative
Approved
8,429
SCOLABAN 400

PubMed

Sample Use Guides

In Vivo Use Guide
It is administered to dogs at the rate of 25 to 50 milligrams per kilogram of body weight. The drug should be given on an empty stomach and food should not be given for 3 hours following treatment.
Route of Administration: Oral
In Vitro Use Guide
Unknown
ACTIVE MOIETY
Structure of BUNAMIDINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966